Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Tax Rate (2016 - 2025)

Historic Tax Rate for Ani Pharmaceuticals (ANIP) over the last 14 years, with Q3 2025 value amounting to 21.3%.

  • Ani Pharmaceuticals' Tax Rate fell 19800.0% to 21.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.82%, marking a year-over-year increase of 143300.0%. This contributed to the annual value of 16.61% for FY2024, which is 111100.0% up from last year.
  • Ani Pharmaceuticals' Tax Rate amounted to 21.3% in Q3 2025, which was down 19800.0% from 19.0% recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Tax Rate registered a high of 37.87% during Q3 2021, and its lowest value of 21.96% during Q4 2023.
  • Moreover, its 5-year median value for Tax Rate was 22.0% (2021), whereas its average is 17.49%.
  • Per our database at Business Quant, Ani Pharmaceuticals' Tax Rate surged by 6727900bps in 2021 and then tumbled by -476100bps in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Tax Rate (Quarter) stood at 21.77% in 2021, then grew by 18bps to 25.65% in 2022, then tumbled by -186bps to 21.96% in 2023, then skyrocketed by 215bps to 25.33% in 2024, then fell by -16bps to 21.3% in 2025.
  • Its Tax Rate was 21.3% in Q3 2025, compared to 19.0% in Q2 2025 and 21.54% in Q1 2025.